Gene55729
ATF7IP: activating transcription factor 7 interacting protein
Cite this record
ConductScience Library. ATF7IP: activating transcription factor 7 interacting protein. Genes, record 55729. Release gene-search-2026-11-13-0.2.1, 13 Nov 2026. https://conductscience.org/library/genes/55729
- Sources
- 13 sources
- Release
- gene-search-2026-11-13-0.2.1
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q6VMQ6 | Activating transcription factor 7-interacting protein 1 | 1,270 | 1 | Ensembl, GeneID, HGNC |
Source UniProt
Patents98
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| US 20260193644 A1 | 2026-07-09 | 1426 | Q6VMQ6 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 36190 | Q6VMQ6 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 36197 | Q6VMQ6 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 1846 | Q6VMQ6 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 1426 | Q6VMQ6 | Espacenet |
| US 20250320254 A1 | 2025-10-16 | 1846 | Q6VMQ6 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 1426 | Q6VMQ6 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 1846 | Q6VMQ6 | Espacenet |
| JP 2025062604 A | 2025-04-14 | 1674 | Q6VMQ6 | Espacenet |
| JP 2025062604 A | 2025-04-14 | 1688 | Q6VMQ6 | Espacenet |
NIH grants448
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | ATF7IP papers | Newest fiscal year |
|---|---|---|---|
| P30CA008748 | Cancer Center Support Grant | 4 | 2025 |
| P40OD010440 | Caenorhabditis Genetics Center | 4 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 3 | 2025 |
| P30CA021765 | Cancer Center Support Grant (CCSG) | 3 | 2025 |
| P30ES009089 | Center for Environmental Health in Northern Manhattan | 3 | 2025 |
| U10CA180886 | COG NCTN Network Group Operations Center - Year 11 STAR Act MCI and PEC Supplement | 3 | 2025 |
| U10CA180899 | Children's Oncology Group Statistics and Data Center | 3 | 2025 |
| ZIACP010144 | Clinical Genetic Studies of Familial and Hereditary Cancer Syndromes | 3 | 2025 |
| P01CA022443 | Molecular Biology and Genetics of Human Tumor Viruses | 2 | 2025 |
| P30CA006927 | Comprehensive Cancer Center Program at Fox Chase | 2 | 2025 |
Source NIH's project files
Papers514
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| An integrated spatially defined roadmap of normal and cancer-associated colon fibroblasts. | Mol Syst Biol | 2026 | 42778665 | PubTator, text mining | PubMed |
| NF-κB-active tumors with matrix CAFs and suppressive immunity as key resistance mechanisms to chemoradiation in rectal cancer. | Exp Mol Med | 2026 | 42552377 | PubTator, text mining | PubMed |
| Tumor stroma-immune interactions shape the immunosuppressive microenvironment and predict response to neoadjuvant chemoradiotherapy plus immunotherapy in rectal cancer. | J Immunother Cancer | 2026 | 42547264 | PubTator, text mining | PubMed |
| Author Correction: ATF7IP/SETDB1-mediated epigenetic programming regulates thymic homing and T lymphopoiesis of hematopoietic progenitors during embryogenesis. | Nat Commun | 2026 | 42350413 | PubTator, text mining | PubMed |
| ATF7ip Inhibits the Tumor Immune Response by Promoting Terminal CD8+ T-cell Exhaustion. | Cancer Immunol Res | 2026 | 41973040 | PubTator, text mining | PubMed |
| Information Security with Smart Hydrogels: Photo-Patterning and Multi-Stimuli Responsive Structural Color. | Nanomicro Lett | 2026 | 41915309 | PubTator, text mining | PubMed |
| Integrated single-cell and spatial transcriptomic analysis reveals mCAF-SPP1⁺ macrophage-T cell crosstalk shaping immunosuppressive niches in colorectal cancer liver metastasis. | J Transl Med | 2026 | 41807965 | PubTator, text mining | PubMed |
| Single-Cell Analysis Reveals Epithelial Heterogeneity and Tumor Microenvironment Characteristics During the Malignant Progression of Colorectal Cancer. | Biomedicines | 2026 | 41751270 | PubTator, text mining | PubMed |
| The Nemp1-Nesprin complex mediates cellular responses to matrix mechanics. | Proc Natl Acad Sci U S A | 2026 | 41730104 | PubTator, text mining | PubMed |
| A toolkit for programmable transcriptional engineering across eukaryotic kingdoms. | bioRxiv | 2026 | 41726944 | PubTator, text mining | PubMed |
None in this release
- Drugs
- Trials
Sources 13
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
- USPTO's sequence listingsPublic domain in the US. Source: United States Patent and Trademark Office, www.uspto.gov
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
- USPTO's sequence listingsUSPTO's sequence listings of patents and published applications, from its bulk data files. No license named for the files. USPTO's terms say "most government-produced materials appearing on this website are not subject to copyright restrictions within the United States and are therefore in the public domain", and ask that USPTO be given appropriate acknowledgement ("Source: United States Patent and Trademark Office, www.uspto.gov"). USPTO does not endorse ConductScience or this release. Read on 12 Nov 2026 at https://www.uspto.gov/terms-use-uspto-websites
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
Source: United States Patent and Trademark Office, www.uspto.gov. USPTO does not endorse ConductScience or this database.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/55729
GET https://conductscience.org/api/genes/v1/55729/patents?page=2